Cargando…

Association of mycophenolic acid dose with efficacy and safety events in kidney transplant patients receiving tacrolimus: an analysis of the Mycophenolic acid Observational REnal transplant registry

Background Dose-finding studies for mycophenolic acid (MPA) in tacrolimus-treated kidney transplant patients are lacking. Methods Data from 901 de novo kidney transplant recipients enrolled in the prospective, non-interventional Mycophenolic acid Observational REnal (MORE) transplant registry were a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doria, Cataldo, Greenstein, Stuart, Narayanan, Mohanram, Ueda, Kimi, Wiland, Anne, McCague, Kevin, Sankari, Bashir, Chan, Laurence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556697/ https://www.ncbi.nlm.nih.gov/pubmed/23121178 http://dx.doi.org/10.1111/ctr.12035

Ejemplares similares

Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry
por: Langone, Anthony, et al.
Publicado: (2013)

Outcomes in Ethnic Minority Renal Transplant Recipients Receiving Everolimus versus Mycophenolate: Comparative Risk Assessment Results From a Pooled Analysis
por: Melancon, Keith, et al.
Publicado: (2013)

Intra-individual variability of mycophenolic acid concentration according to renal function in liver transplant recipients receiving mycophenolate monotherapy
por: Hwang, Shin, et al.
Publicado: (2017)

Improved Gastrointestinal Symptoms and Quality of Life after Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus
por: Hwang, Hyeon Seok, et al.
Publicado: (2010)

Methylprednisolone/mycophenolic-acid/tacrolimus: Genital herpes: case report
Publicado: (2021)

Mycophenolic acid AUC in Thai kidney transplant recipients receiving low dose mycophenolate and its association with UGT2B7 polymorphisms
por: Pithukpakorn, Manop, et al.
Publicado: (2014)

Estimation of Mycophenolic Acid Area Under the Curve With Limited-Sampling Strategy in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium
por: Jia, Yichen, et al.
Publicado: (2017)

Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study
por: Kim, Deok Gie, et al.
Publicado: (2022)

The Effect of Tacrolimus and Mycophenolic Acid on CD14+ Monocyte Activation and Function
por: Kannegieter, Nynke M., et al.
Publicado: (2017)

Mycophenolic-acid/prednisone/tacrolimus: COVID-19 pneumonia: case report
Publicado: (2021)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2014)

Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation
por: Sobiak, Joanna, et al.
Publicado: (2015)

Age associations with tacrolimus and mycophenolic acid pharmacokinetics in stable Black and White kidney transplant recipients: Implications for health inequities
por: Tornatore, Kathleen M., et al.
Publicado: (2023)

Nonlinear relationship between enteric-coated mycophenolate sodium dose and mycophenolic acid exposure in Han kidney transplantation recipients
por: Zhang, Jun, et al.
Publicado: (2017)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

Transplant Prognosis in Kidney Transplant Recipients with Diabetes under Mycophenolic Acid-Focused Therapeutic Drug Monitoring
por: Nakamura, Eisuke, et al.
Publicado: (2021)

Mycophenolic acid formulations in adult renal transplantation – update on efficacy and tolerability
por: Golshayan, Déla, et al.
Publicado: (2009)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
por: Dalal, P, et al.
Publicado: (2010)

Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus
por: Shihab, F., et al.
Publicado: (2017)

Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation
por: Peters, Fleur S., et al.
Publicado: (2017)

Neutrophil Gelatinase-Associated Lipocalin Is Not Associated with Tacrolimus-Induced Acute Kidney Injury in Liver Transplant Patients Who Received Mycophenolate Mofetil with Delayed Introduction of Tacrolimus
por: Fukuda, Mio, et al.
Publicado: (2019)

Mycophenolate-mofetil/prednisone/tacrolimus: Infections: case report
Publicado: (2020)

Mycophenolate mofetil/tacrolimus: Cutaneous leishmaniasis: case report
Publicado: (2021)

Mycophenolate-mofetil/tacrolimus: COVID-19: case report
Publicado: (2022)

Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats
por: Slovak, J.E., et al.
Publicado: (2017)

Administration of mycophenolic acid is not associated with malformations in descendants from kidney transplanted males
por: Lopez-Lopez, Isabel, et al.
Publicado: (2018)

Quantitation of mycophenolic acid and metabolites by UPLC-MS/MS in renal transplant patients
por: Huang, Yun-Fen, et al.
Publicado: (2022)

New-Onset Diabetes Mellitus in Post-renal Transplant Patients on Tacrolimus and Mycophenolate: A Systematic Review
por: Nandula, Savitri Aninditha, et al.
Publicado: (2022)

Amphotericin-B liposomal /mycophenolic acid/tacrolimus: Mucormycosis and lack of efficacy: 2 case reports
Publicado: (2021)

Dynamic Monitoring of Intracellular Tacrolimus and Mycophenolic Acid Therapy in Renal Transplant Recipients Using Magnetic Bead Extraction Combined with LC-MS/MS
por: Xu, Huan, et al.
Publicado: (2023)

Mycophenolate/prednisone/tacrolimus: Guillain-Barre syndrome: case report
Publicado: (2020)

Mycophenolate/tacrolimus: Worsening of COVID-19 infection: case report
Publicado: (2021)

Mycophenolate mofetil/tacrolimus: COVID-19 infection: case report
Publicado: (2021)

Methylprednisolone/mycophenolate-mofetil/tacrolimus: Pneumatosis intestinalis: case report
Publicado: (2021)

Mycophenolate mofetil/prednisone/tacrolimus: Disseminated blastomycosis: case report
Publicado: (2021)

Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
por: Oh, Chang-Kwon, et al.
Publicado: (2012)

Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention
por: Metz, David K., et al.
Publicado: (2014)

The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients
por: AbdElhalim, Mohamed S., et al.
Publicado: (2020)

Clinical Implication of Mycophenolic Acid Trough Concentration Monitoring in Kidney Transplant Patients on a Tacrolimus Triple Maintenance Regimen: A Single-Center Experience
por: Rhu, Jinsoo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_augf91sp3dmr2qa49c46ag6sam